← Back to Clinical Trials
Recruiting NCT07756541

NCT07756541 POP SINGER Randomized Clinical Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07756541
Status Recruiting
Phase —
Sponsor University Hospitals Cleveland Medical Center
Condition Chronic Pain
Study Type INTERVENTIONAL
Enrollment 130 participants
Start Date 2026-07-29
Primary Completion 2028-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
YogaMusic Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 130 participants in total. It began in 2026-07-29 with a primary completion date of 2028-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Conduct a feasibility randomized controlled trial (N = 130, 65 per group) comparing the POPSINGER music therapy (MT) intervention to yoga.

Eligibility Criteria

Inclusion Criteria: 1. Adults aged 18 and older 2. Reporting pain on most days per month for a duration of ≥3 months 3. Independently ambulatory (i.e., able to walk 10 feet without a cane or walker) 4. Willing to participate in the full scope of the program 5. Access to internet, active email address, \& laptop, tablet, and/or PC with videoconferencing capabilities 6. Have reliable access to a mobile device with an active data plan at home and is comfortable accessing the internet and their email with this device 7. Able to read and understand English Exclusion Criteria: 1. Significant hearing and/or visual impairment 2. Have had a major surgery (e.g., spine surgery, joint replacement) within the past 6 months 3. Have a planned surgery within the next 6 months at the time of enrollment 4. Unable to independently provide consent (i.e., no proxy consent) 5. Active suicidal ideation 6. Severe psychological comorbidity (e.g., psychosis, schizophrenia) that would prevent patient from engaging fully in intervention 7. Receiving active cancer treatment. 8. Diagnosed with medical condition likely to be terminal within 24 weeks 9. Either (a) active substance abuse of cocaine, heroin, cannabis, or alcohol or (b) unmanaged opioid use disorder diagnosis present within the EHR in the last 6 months 10. Currently receiving music therapy from a professional music therapist 11. Currently engaged in regular weekly yoga practice

Contact & Investigator

Central Contact

Nita Hoxha, MBA

✉ Nita.Hoxha@uhhospitals.org

📞 216-286-6219

Frequently Asked Questions

Who can join the NCT07756541 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07756541 currently recruiting?

Yes, NCT07756541 is actively recruiting participants. Contact the research team at Nita.Hoxha@uhhospitals.org for enrollment information.

Where is the NCT07756541 trial being conducted?

This trial is being conducted at Cleveland, United States.

Who is sponsoring the NCT07756541 clinical trial?

NCT07756541 is sponsored by University Hospitals Cleveland Medical Center. The trial plans to enroll 130 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology